1-4 of 4
Brian A. Fox, PhD
Close
Sort by
Journal Articles

Association of Baseline and Postinfusion Biomarkers with Safety and Efficacy Endpoints in Patients Treated with Orvacabtagene Autoleucel (orva-cel; JCARH125) in the Phase 1/2 Evolve Study (NCT03430011)

Julia Piasecki, BA, Todd Devries, PhD, Aditya Radhakrishnan, PhD, Yan Li, PhD, Mark Heipel, BS, Brian A. Fox, PhD, Valeria Beckett, MS, Mariana Cota Stirner, MD PhD, Kristin Conte, MPH, Thomas Doerr, MSc, Sham Mailankody, MBBS, Sandy W. Wong, MD, Philip L. McCarthy, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 2–3.
https://doi.org/10.1182/blood-2020-137786
Published: 2020
Journal Articles

Baseline and on-Treatment Bone Marrow Microenvironments Predict Myeloma Patient Outcomes and Inform Potential Intervention Strategies

Samuel A Danziger, PhD, Mark McConnell, PhD, Jake Gockley, PhD, Mary Young, PhD, Adam Rosenthal, MS, Frank Schmitz, MD PhD, David Reiss, PhD, Phil Farmer, Cody Ashby, PhD, Michael A Bauer, PhD, Frits van Rhee, MD PhD, Faith E. Davies, MD, Maurizio Zangari, MD, Nathan Petty, MS, CCRP, Wilbert B. Copeland, PhD, Brian A. Fox, PhD, Antje Hoering, PhD, Alison Fitch, Katie Newhall, PhD, Bart Barlogie, MD PhD, Brian A Walker, PhD, Matthew Trotter, PhD, Rob Hershberg, MD PhD, Andrew Dervan, Alexander Ratushny, PhD, Gareth Morgan, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1882.
https://doi.org/10.1182/blood-2018-99-113169
Published: 2018
Journal Articles

Immune Microenvironment Analysis of Bone Marrow By Mass Cytometry and RNA Sequencing in Multiple Myeloma Patients Treated with Daratumumab and Durvalumab

Frances Seymour, MRCP, BSc, MBBS, Mary H Young, PhD, Mark Tometsko, BSc, Jamie Cavenagh, MD PhD, Ethan G. Thompson, PhD, Elizabeth Whalen, PhD, Sam A Danziger, Alison Fitch, Brian A. Fox, PhD, Andrew Dervan, Teri Foy, PhD, Katie Newhall, PhD, John G. Gribben
Journal: Blood
Blood (2018) 132 (Supplement 1): 3296.
https://doi.org/10.1182/blood-2018-99-114453
Published: 2018
Journal Articles

Comprehensive Immune Profiling from Peripheral Blood and Bone Marrow in Newly Diagnosed and Relapsed/Refractory Multiple Myeloma Patients Reflects Differences in Immune Subsets and Activation Status

Greg E. Pietz, BS, MS, Mark Tometsko, BSc, Wilbert B. Copeland, PhD, Elizabeth Whalen, PhD, Frank Schmitz, MD PhD, Ethan G. Thompson, PhD, Amit Agarwal, MD PhD, Teresa Foy, PhD, Lauren Buchholz, BS, Vitalina Komashko, PhD, Justine Dell'Aringa, BSc, Brian A. Fox, PhD, Kathryn Newhall, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3161.
https://doi.org/10.1182/blood-2018-99-115107
Published: 2018